For research use only, not for therapeutic use.
MC-Val-Cit-PAB-MMAF is a drug-linker conjugate for ADC with antitumor activity by using the tubulin inhibitor, MMAF, linked via cathepsin cleavable MC-Val-Cit-PAB.
| Catalog Number | I017897 |
| CAS Number | 863971-17-9 |
| Molecular Formula | C₆₈H₁₀₃N₁₁O₁₆ |
| Purity | ≥95% |
| Reference | [1]. Cheng X, et al. MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity. Mol Cancer Ther. 2018 Dec;17(12):2665-2675. |
